| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 1.4 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |